GLG News by Physicians who Treat Dry Eye (US)
Articles with lock require a subscription to GLG News |
Request a free trial
November 13, 2008Will contact lens solutions cost more to ship and store?
Analysis of: Eye Infection Epidemic Traced To Reduced Antifungal Properties Of Contact Lens Solution In High Temperatures | www.medicalnewstoday.com
Author: Steve Rubinstein, Optometrist, Sound Shore Vision Care
A new study in Archives of Ophthalmology, November 2008 indicates that a reason for the large number of infections from Bausch & Lomb's Renu Moisture Loc solution was due to poor temperature control reducing antifungal and antimicrobial efficacy.
November 4, 2008Lasik, Pharma, and Cataracts...are they recession proof?
Analysis of: Value Stocks in the Eye of the Storm? | news.morningstar.com
Author: Steve Rubinstein, Optometrist, Sound Shore Vision Care
The article goes into the four major eye care markets that have a mix of reimbursed, and consumer driven areas. It describes the issues I face as a provider of these products.
October 6, 2008A new lens for computer users?
Analysis of: PixelOptics focuses on new lens | www.roanoke.com
Author: Steve Rubinstein, Optometrist, Sound Shore Vision Care
This eyeglass lens designer, Ron Blum has created a new type of Progressive Addition Lens about 6 years ago. It created a new market in Ultra-Premium lenses. Now he is attempting to create a new lens for computer users. I look forward to its introduction next month, and to the creation of new profit...
September 22, 2008Working with Silcione Hydrogels is not easy!
Analysis of: Ahead of the Bell: Cooper Cos. | www.forbes.com
Author: Steve Rubinstein, Optometrist, Sound Shore Vision Care
This article mentions two major contact lens manufacturers, CooperVision and Vistakon (a subsidiary of Johnson & Johnson), with difficulties actually making silicone hydrogel contact lenses that can be sold successfully.
September 22, 2008A new Contact Lens material by 2009?
Analysis of: Ocutec wins backing for contact lens venture | www.theherald.co.uk
Author: Steve Rubinstein, Optometrist, Sound Shore Vision Care
A new material that is easier to produce contact lenses with may decrease the cost of producing contact lenses. A major difficulty in producing today's silicone hydrogels is production costs.
September 4, 2008
Laser is better than Steroids in the Management of Diabetic Macular Edema.
Analysis of: A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Focal/Grid Photocoagulation for Diabetic Macular Edema | www.ophsource.org
Author: GLG Expert Contributor
Laser is better than Steroids in the Management of Diabetic Macular Edema.Analysis of: A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Focal/Grid Photocoagulation for Diabetic Macular Edema | www.ophsource.org
Author: GLG Expert Contributor
This Phase III Clinical Trial clearly shows that focal grid laser is better than steroids in the management of Diabetic Macular Edema (DME). This reaffirms laser as the current gold standard in the management of DME and casts doubts on numerous treatment modalities in the pipeline that use steroids...
August 26, 2008New non steroidal anti-inflamatory for diabetic retinopathy?
Analysis of: Pfizer Inc. Cancels Phase III of Glaucoma Drug Research in Asia | www.biospace.com
Author: Steve Rubinstein, Optometrist, Sound Shore Vision Care
The new prostaglandin analog is not what i find interesting in this article. A new treatment for Diabetic Retinopathy sounds much more interesting
August 19, 2008Visian ICL: Premium Channel for the Extremely Nearsighted
Analysis of: Insiders Buy Staar as Lasik Alternate Shows Potential (Update2) | www.bloomberg.com
Author: Mark Packer, Clinical Associate Professor of Ophthalmology, OREGON HEALTH & SCIENCE UNIVERSITY - CC
The Visian ICL (Implantable Collamer Lens) is an exquisitely precise technology for the correction of high degrees of nearsightedness -- much higher than the reach of laser refractive surgery such as LASIK and PRK. Given the price of the ICL and the intraocular surgey required for its...
July 21, 2008Ultimately, the Patient, Not the Payor, is the Customer
Analysis of: Glaxo Seeks Guidance From Health Systems | online.wsj.com
Author: Mark Packer, Clinical Associate Professor of Ophthalmology, OREGON HEALTH & SCIENCE UNIVERSITY - CC
"He who pays the fiddler calls the tune." Here's an example of the fiddler pro-actively asking the guy in the room with the deepest pocket what he'd like to hear. If it's not something in the current repertoire, the fiddler seems willing to learn. However, by the time he's got...
July 3, 2008An illegal use of Lumigan, now legal?
Analysis of: Longer Lashes in a Tube? Maybe Not | www.nytimes.com
Author: Steve Rubinstein, Optometrist, Sound Shore Vision Care
A few months ago, a small company tried to import Lumigan (bimatoprost), licensed by Allergan, in an eyelash applicator. It was held by the FDA as an unapproved use of a prescription medication. Now the owner of the patent is trying to import the same drug legally.
Page : 1 2 3 4 5 6 7 8 9 10 Next1 to 10 of 167
More GLG News in
Healthcare
Most Popular:
Source Article | Expert Analyses
Painkiller Risk Found for Heart Patients
www.nytimes.com
FDA Asks if Pain Pill Is Tamper-Proof
online.wsj.com
Merck KGaA: Overall Survival in First-Line NSCLC Reaches 15 Months
www.pipelinereview.com
Hospitals See Drop in Paying Patients
www.nytimes.com
Gardasil, Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males in Phase III Study
www.fiercebiotech.com
Is Celebrex Next ?
November 18, 2008
Will contact lens solutions cost more to ship and store?
November 13, 2008
Economy's impact on healthcare facilities
November 13, 2008
Tamper Proof Narcotic Pain pill? YES
November 13, 2008
A closer look
November 11, 2008